-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Nektar Therapeutics quarterly/annual Return On Assets history and growth rate from 2011 to 2023.
- Nektar Therapeutics Return On Assets for the quarter ending June 30, 2024 was -44.8 %, a 6.93% increase year-over-year.
- Nektar Therapeutics annual Return On Assets for 2023 was -58.2 %, a 33.6% decline from 2022.
- Nektar Therapeutics annual Return On Assets for 2022 was -43.6 %, a 8.67% decline from 2021.
- Nektar Therapeutics annual Return On Assets for 2021 was -40.1 %, a 47.4% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)